Tag: Fampyra

NICE opts to reject Acorda’s MS drug Fampyra

by John Pinching | Jun 22, 2022 | News | 0

The MS Society responds as MS therapy Fampyra is rejected

SMC accepts four medicines for NHS use

by Selina McKee | Apr 14, 2020 | News | 0

Biogen’s Famprya, Sanofi’s Suliqua, Janssen’s Stelara and Shionogi Rizmoic will be funded on the NHS in Scotland

SMC endorses EUSA Pharma’s Qarziba

by Selina McKee | Nov 13, 2018 | News | 0

A medicine used to treat a rare cancer that predominantly occurs in very young children is to be routinely funded on the NHS in Scotland.

Full green light for Biogen’s MS drug Fampyra

by Selina McKee | May 24, 2017 | News | 0

Biogen’s Fampyra has been granted a standard approval by European regulators on the back of late-stage data supporting its use to improve walking in patients with multiple sclerosis.

SMC endorses use of five meds on NHS Scotland

by Selina McKee | Nov 7, 2016 | News | 0

The Scottish Medicines Consortium has endorsed the use of five new therapies by NHS Scotland to treat melanoma, ovarian cancer, hepatitis C, Fabry disease and bacterial vaginosis.